News und Analysen

Even with all the volatility and the flirting with bear-market territory, the S&P 500 index is well in the green this year, up about 8% since early January. Some stocks haven't been so lucky

Helix Energy Solutions Group (NYSE:HLX), a diversified offshore energy services provider, reported weaker-than-expected Q2 2025 results, released on July 23, 2025. The headline was a disappointing

On July 10, 2025, Stewart Murray Lee (Head of People & Strategy) executed an open market sale of 50,000 shares of New Horizon Aircraft Ltd.(NASDAQ:HOVR), with the transaction disclosed in a Form 4

Here's our initial take on Novocure's (NASDAQ: NVCR) fiscal 2025 second-quarter financial report.

Novocure reported no surprises in its latest quarter, with revenue up 6% for the year and both

It's been a challenging past three years for AbbVie (NYSE: ABBV). The pharmaceutical leader lost U.S. patent exclusivity for its top-selling medicine, Humira, and encountered a significant clinical

It's been a rough year for Sarepta Therapeutics (NASDAQ: SRPT), a small-cap biotech that develops medicines for rare diseases. The company's shares are down by 88% year to date due to safety issues

Viking Therapeutics (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on treatments for obesity and metabolic diseases, released results for its second quarter on July 23, 2025. The

AT&T (NYSE: T) released its latest set of quarterly results Wednesday morning. While these weren't strong enough to bring the bulls charging into the stock, they were nevertheless pleasing for

AT&T (NYSE:T), a U.S. telecommunications and connectivity provider, released its Q2 2025 earnings on July 23, 2025. The company posted adjusted earnings per share of $0.54, just above the average

First Horizon (NYSE:FHN), a regional banking group focused on retail and commercial lending in the Southeast, released its second quarter 2025 earnings on July 16, 2025. The most important news was

AT&T (NYSE:T), a major U.S. telecommunications company known for wireless and fiber broadband services, released its second-quarter 2025 results on July 23, 2025. The company reported revenue of

Nvidia (NASDAQ: NVDA) shares declined 2.5% to close at $167.03 on July 22 as investors engaged in profit-taking following the stock's post-earnings rally. Approximately 183 million shares of the

Eli Lilly (NYSE: LLY) and Viking Therapeutics (NASDAQ: VKTX) have garnered considerable attention over the past year due to their solid clinical progress. However, these drugmakers have also lagged

The trade war between the U.S. and China recently took an unexpected turn, and the biggest beneficiaries look to be Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD). Both stocks popped

Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, long-term investors should have a balanced approach to potentially

AT&T (NYSE: T) stock moved higher in Monday's trading. The telecommunications company's share price gained 1.6% in the daily session amid a 0.1% gain for the S&P 500 index and a 0.3% gain for the

In today's video, I discuss recent updates affecting Intel (NASDAQ: INTC) and Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the

In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and other semiconductor companies. To learn more, check out the short video,

Three years ago, Summit Therapeutics (NASDAQ: SMMT) was a little-known small-cap biotech that few investors with an average tolerance for risk would have bothered to pay attention to at the time

Pharmaceutical giants Pfizer (NYSE: PFE) and Novo Nordisk (NYSE: NVO) have lagged the market over the past year, although Pfizer's poor performance dates back much further. Though these companies

There is a lot you can do with $1,000. But if you want to get a step closer to sustainable wealth, consider putting that money to work in the stock market. The burgeoning generative artificial

Where can you find the next monster stocks? Check out the biotech space. It's not easy, but investors can sometimes find highly promising biotech stocks that are only in their early innings.

Three

President Donald Trump's trade policies have caused tumult on Wall Street. The president has pushed for aggressive tariffs on imported goods in an attempt to bring manufacturing jobs back to the